Skip to main content

Policy Notices

Policy process
 
 
 
 
 

The table below shows Pending policy notices with detailed Item name, board action date, and target implementation date

ItemActionTarget implementation date
National Heart Review Board for Pediatrics 6/2020 Board action 06/15/2021
Align OPTN Policy with US PHS Guideline 2020
  • Policy 14.8.B: Living Donor Specimen Collection and Storage
  • Policy 14.3: Informed Consent Requirements
12/2020 Board action 06/2021
Combined Policy Notice for VCA Membership Requirements (2020)
VCA Membership Bylaws Requirements
VCA - List Covered Body Parts - 1 of 2
  • Policy 1.2: Definitions
  • Bylaws Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs; Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs; and Appendix M: Definitions
Align VCA Program Membership Requirements with Other Programs
6/2015, 6/2016, 6/2018 Board action 06/2021
Human Leukocyte Antigen (HLA) Equivalency Tables Update 2020 6/2020 Board action 06/2021
Changes to Islet Bylaws 12/2018 Board action 06/2021
Updated Cohort for Calculation of the LAS 12/2020 Board action 07/2021
Modify Data Submission Policies 12/2019 Board action 08/2021
Further Enhancements to the National Liver Review Board 12/2020 Board action 09/2021
OPTN Data Collection Changes: Update to VCA Transplant Outcomes Data Collection 12/2020 Board action 06/2022
Programming VCA Allocation in UNet 12/2020 Board action 06/2022
Modify Data Collection on Living VCA Donors (pending OMB approval) 12/2020 Board action 06/2022

The table below shows Implemented policy notices with detailed Item name, board action date, and effective implementation date

ItemActionEffective date
Implemented policy items in 2021    

Expedited Liver Placement

12/2019 Board action 3/25/2021

Pancreas Removal of DSA

12/2019 Board action 03/15/2021

Kidney Removal of DSA

12/2019 Board action 03/15/2021

Addressing Medically Urgent Candidates in New Kidney Allocation Policy

6/2020 Board action 03/15/2021

Distribution of Kidneys and Pancreata from Alaska

6/2020 Board action 03/15/2021

Modifications to Released Kidney and Pancreas Allocation

6/2020 Board action 03/15/2021

Guidance and Policy Addressing Adult Heart Allocation

  • Policy 6.1.A.ii: Non-dischargeable, surgically implanted, non-endovascular biventricular support device: Effective March 4, 2021
  • Policy 6.1.C.vi: Mechanical Circulatory Support Devise (MCSD) with Device Infection: Effective March 4, 2021
  • Policy 6.1.D.ii: Inotropes without Hemodynamic Monitoring: Effective March 4, 2021
  • Guidance for Adult Heart Exceptions for
    Status 2 Candidates Experiencing Cardiogenic Shock: Effective February 9, 2021
12/2020 Board action 2/9/2021, 3/4/2021

Align OPTN Policy with US PHS Guideline 2020

Split implementation. Additional actions targeted for June 2021 implementation.

  • 1.2: Definitions
  • 2.2: OPO Responsibilities
  • 2.4: Deceased Donor Medical and Behavioral History
  • 2.5: Hemodilution Assessment
  • 2.7.A: Exceptions to HIV Screening Requirement
  • 2.9: Required Deceased Donor Infectious Disease Testing
  • 13.11:  Receiving and Accepting KPD Match Offers
  • 14.1.A: Living Donor Psychosocial Evaluation Requirements
  • 14.4.A: Living Donor Medical Evaluation Requirements
  • 14.9.B: Psychosocial and Medical Evaluation Requirements for Domino and Non-Domino Therapeutic Donors
  • 15.2:  Potential Candidate Screening Requirements
  • 15.3.B: Donors with  Risk Identified Pre-Transplant
  • 15.3.C: Recipients of Organs from Donors with   Increased Risk of Disease Transmission
  • 16.3.D: internal labeling of Extra Vessels
12/2020 Board action 03/2021

Guidance Addressing the Use of Pediatric Heart Exceptions

12/2020 Board action 2/9/2021
Further Enhancements to the National Liver Review Board
  • Split implementation. Additional actions targeted for June 2021 implementation.
  • Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exception Review
12/2020 Board action 2/9/2021
Implemented policy items in 2020    
Establish Pediatric Training and Experience 12/2015 Board actions 12/7/2020
Revise Pediatric Emergency Membership Exception Pathway 12/2017 Board action 12/7/2020
Incorporating COVID-19 Related Organ Failure In Candidate Listings 10/2020 Board action 10/28/2020
Enhancements to the National Liver Review Board
  • Policies 9.4.A: MELD or PELD Score Exception Requests and 9.4.D: Calculation of Median MELD or PELD at Transplant: Effective August 4, 2020
  • Operational Guidelines: Effective August 4, 2020
  • Operational Guidance: Effective August 4, 2020
  • Policies 9.4.C: MELD or PELD Score Exception Extensions and 9.5.I.vii: Extensions of HCC Exceptions: Effective September 10, 2020
6/2020 Board action 8/4/2020, 9/10/2020
Guidance and Policy Modifications Addressing Blood Type Determination
  • Guidance: Effective June 8, 2020
  • Policy: Effective September 1, 2020
6/2020 Board action 6/8/2020,9/1/2020
Modify the Conflicts of Interests Bylaws 6/2020 Board action 7/1/2020
Creation of OPTN Heart and Lung Committees 3/2020 Board action 7/1/2020
Modify Lung TRF to Improve Post Transplant Lung Function Data 6/2018 Board action 6/30/2020
Eliminate the Use of Regions in VCA Distribution 6/2019 Board action 6/18/2020
Modify HOPE Act Variance to Include Other Organs 6/2019 Board action 5/21/2020
COVID-19 Emergency Policy Package 04/2020 Executive Committee action 4/3/2020
Clarifications on Reporting Maintenance Dialysis 6/2019 Board action 4/1/2020
Updates to Candidate Data During 2020 COVID-19 Emergency 03/2020 Executive Committee action 3/17/2020
Variances Removal Policy Notice 12/2019 Board action 3/1/2020
Clarification of Pre-Existing Liver Disease 12/2019 Board action 3/1/2020
Addressing HLA Typing Errors 12/2018 Board action 2/27/2020
Access for Urgent Liver Candidates in Hawaii & Puerto Rico 01/2020 Executive Committee action 2/18/2020
Liver and Intestine Distribution Using Distance from Donor Hospital 12/2018 Board action 2/4/2020
Reduce Reporting Burdens and Clarify Policies on Extra Vessels
  • Table 16.1: Required information on internal labels for extra vessels, number 7 (donor infectious disease results)
6/2018 Board action 1/29/2020
Update Transplant Hospital Definition 12/2016 Board action 1/13/2020
Eliminate the Use of DSAs in Thoracic Organ Distribution 6/2019 Board action 1/9/2020
Implemented policy items in 2019    
Adding DR Antigens and Equivalences 12/2019 Board Action 12/4/2019
Hope Act Policy and Mini Brief 12/2019 Board action 12/3/2019
Modify Appointment Process for the Histocompatibility Vice Chair 12/2019 Board Action 12/3/2019
Aligning Units of Distribution in Closed Variance for Split Liver Transplantation 12/2019 Board Action 12/3/2019
Split Liver Variance 6/2019 Board action 12/3/2019
Revising Priority Points in Kidney Paired Donation Program 12/2015 Board action;
10/2019 Executive Committee action
10/24/2019
Improving Dual Kidney Allocation 12/2017 Board action 9/2019
Improving en Bloc Kidney Allocation 12/2017 Board action 9/2019
Changes to Waiting Time Criteria for Kidney-Pancreas Candidates 6/2018 Board action 7/11/2019
Guidance on Effective Practices in Organ Distribution 6/2019 Board action 6/10/2019
Ethical Implications of Multi-Organ Transplants White Paper 6/2019 Board action 6/10/2019
Revised National Liver Review Board Policies 12/2018 Board action 5/14/2019
National Liver Review Board 6/2017 Board action 5/14/2019
Histocompatibility Bylaws Rewrite: General Supervisor 6/2015 Board action 3/1/2018
Pancreas Program Functional Inactivity 12/2018 Board action 4/8/2019
Addressing HLA Typing Errors
  • Policy 2.2 (OPO responsibilities)
  • Bylaws C.2.D (OPO affiliation)
12/2018 Board action 3/1/2019
Amend CPRA Calculator 1/2019 Executive Committee action 1/17/2019
Implemented policy items in 2018    
Change to Hospital-Based OPO Voting Privileges 12/2018 Board action 12/4/2018
Frameworks for Organ Distribution 12/2018 Board action 12/4/2018
Pediatric Transition and Transfer Guidance 12/2018 Board action 12/3/2018
Intestine Membership Bylaws Requirements 6/2015 Board action 11/20/2018
Modify Adult Heart Allocation 12/2016 Board action 10/18/2018
Clarification of Adult Heart Allocation 8/2017 Executive Committee action 10/18/2018
Review Board Guidance on HCM and RCM Exceptions 6/2018 Board action 10/18/2018
Modifications to the Distribution of Deceased Donor Lungs 6/2018 Board action 10/18/2018 (Policy 6.6.F)
6/12/2018 (Policies 1.2, 10.2.A, 10.4)
Clarify Informed Consent Policies for Transmittable Diseases 6/2018 Board action 9/1/2018
Reduce Reporting Burdens and Clarify Policies on Extra Vessels 6/2018 Board action 9/1/2018 (except table 16.1)
VCA - List Covered Body Parts (2 0f 2)
  • Bylaws Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs: Effective September 1, 2018
  • Policy 1.2: Definitions: Target implementation date: December 2021
  • Bylaws Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs; Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs; and Appendix M: Definitions: Target implementation date: December 2021
6/2016 Board action 9/1/2018
Improving the Efficiency of Organ Allocation 12/2017 Board action 3/1/2018 (Policies 2.2, 2.11 and 2.12)
5/2/2018 (Policies 1.2 and 5.6.B)
6/12/2018 (Policies 2.11.A and 2.11.D)
6/13/2018 (Policy 5.6.C)
Revising OPTN Bylaws Appendix L 6/2018 Board action 6/12/2018
Retrospective Review of Clerical Policy Changes 6/2018 Executive Committee action 6/12/2018
Approved Transplant Fellowship Training Programs Bylaws 12/2017 Board action 3/1/2018
Definition of Pancreas Graft Failure 6/2015 Board action 2/28/2018
Modification to HCC Extension Criteria   2/5/2018
Implemented policy items in 2017    
HCC Auto Approval Criteria Changes 12/2016 Board action
12/2017 Executive Committee action
12/12/2017
Lung Allocation Policy Modification 11/2017 Executive Committee action 11/24/2017
Standardize Organ Coding and Tracking System 2/2017 Executive Committee action 11/01/2017
Improve the Categorization of Living Donor Events 9/2017 executive committee action 10/18/2017
Add DQA-1 Equivalences Table 6/2016 Board action
6/2017 Executive Committee action
9/12/2017
Update HLA Equivalency Tables 12/2015 Board action
4/2017 Executive Committee action
9/12/2017
Personnel Procurement Requirements 12/2015 Board action 9/1/2017
Foreign Equivalent in Bylaws 12/2015 Board action 9/1/2017
Bylaws Rewrite 6/2017 Board action 9/1/2017
Primary Kidney Transplant Physician Update 12/2016 Board action 9/1/2017
Clarification to Apply Kidney Minimum Acceptance Criteria to Highly Sensitized Candidates 7/2017 Executive Committee action 9/1/2017
Simultaneous Liver-Kidney Allocation 6/2016 Board action 8/10/2017
Kidney: KAS Clarifications (part) 6/2016 Board action 6/29/2017
Retrospective Review of Clerical Changes to Policies 6/2017 Executive committee action 6/29/2017
Informed Consent Changes - Potential Living Donors 12/2016 Board action 6/1/2017
Improving Post-Transplant Communication (part) 6/2016 Board action; Required toxoplasmosis testing of all donors 4/6/2017
Pediatric Lung Allocation Changes 12/2015 Board action 3/30/2017
All Other KPD Guidelines to Policy (part) 6/2015 Board action 3/30/2017
Post-Implementation ABO Policy Changes 12/2016 Board action 3/1/2017
Primary Transplant Surgeon Changes 12/2016 Board action 3/1/2017
Primary Transplant Physician Subspecialty Changes 12/2016 Board action 3/1/2017
Remove Donor Location from Required Procurement Log 12/2016 Board action 3/1/2017
Changes to Imminent and Eligible Definitions 12/2016 Board action 1/1/2017
Implemented policy items in 2016    
Retrospective Review of Clerical Changes to Policies 12/2016 Executive committee action 11/10/2016
Registration Fee 6/2016 Board action 10/1/2016
DTAC Policy Clarification 6/2016 Executive Committee action 9/1/2016
OSC Policy Clarification 8/2016 Executive Committee action 9/1/2016
HOPE Act 6/2016 Board action 9/1/2016
Improving Post-Transplant Communication (part) 6/2016 Board action 9/1/2016
Kidney: KAS Clarifications (part) 6/2016 Board action 9/1/2016
Regional Councillor Vacancy 6/2016 Board action 9/1/2017
Living Donor Candidate Registration 4/2016 Executive Committee action 4/14/2016
Retrospective Review of Clerical Changes to Policies 12/2016 Executive committee action 4/14/2016
Implemented policy items in 2015    
KPD Informed Consent 6/2015 Board action 12/1/2015

COVID-19 Emergency Policies and Data Collection

Implemented

  • 1.4.F: Updates to Candidate Data during 2020 COVID-19 Emergency
  • 2.11: Required Deceased Donor Information
  • 3.7.D: Applications for Modification of Kidney Waiting Time during 2020 COVID-19 Emergency
  • 18.1: Data Submission Requirements
  • 18.1.A: Retrospective Data Collection during COVID-19 Emergency
  • 18.2: Timely Collection of Data
  • 18.5.A: Reporting Requirements after Living Kidney Donation
  • 18.5.B: Reporting Requirements after Living Liver Donation